Literature DB >> 12082607

Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras.

Karen L MacKenzie1, Sonia Franco, Afzal J Naiyer, Chad May, Michel Sadelain, Shahin Rafii, Malcolm A S Moore.   

Abstract

We have modelled multiple stages of malignant transformation of human endothelial cells (ECs) by overexpressing the catalytic subunit of human telomerase (hTERT), together with SV40 T antigen (SV40T) and oncogenic N-ras. Transfection with hTERT alone, led to the immortalization of two out of three cultures of bone marrow-derived ECs (BMECs). One hTERT transduced BMEC culture underwent a long proliferative lag before resuming proliferation. BMECs transfected with hTERT alone were functionally and phenotypically normal. BMECs transfected with SV40T (BMSVTs) had an extended lifespan, but eventually succumbed to crisis. BMSVTs exhibited a partially transformed phenotype, demonstrating growth factor independence, altered antigen expression and forming tiny, infrequent colonies in vitro. Transduction of BMSVTs with hTERT resulted in immortalization of 4 out of 4 cultures. BMSVTs immortalized with hTERT formed large colonies in vitro and small transient tumours in vivo. BMECs co-expressing SV40T, hTERT and N-ras exhibited an overtly transformed phenotype; forming very large colonies with an altered morphology and generating rapidly growing tumours in vivo. These investigations demonstrate transformation of human ECs to an overtly malignant phenotype. This model will be useful for understanding mechanisms underlying vascular and angiogenic neoplasias, as well as for testing drugs designed to curtail aberrant EC growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082607     DOI: 10.1038/sj.onc.1205425

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

Review 1.  The renewed battle against RAS-mutant cancers.

Authors:  Fuquan Zhang; Jit Kong Cheong
Journal:  Cell Mol Life Sci       Date:  2016-02-18       Impact factor: 9.261

2.  Benign mesenchymal stromal cells in human sarcomas.

Authors:  Alexei Morozov; Robert J Downey; John Healey; Andre L Moreira; Emil Lou; Anna Franceschino; Yildirim Dogan; Roland Leung; Mark Edgar; Michael LaQuaglia; Robert G Maki; Malcolm A S Moore
Journal:  Clin Cancer Res       Date:  2010-12-01       Impact factor: 12.531

3.  Immortalization of human umbilical vein endothelial cells with telomerase reverse transcriptase and simian virus 40 large T antigen.

Authors:  Chang Bian; Kui Zhao; Guo-xin Tong; Yong-liang Zhu; Peng Chen
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

4.  Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts.

Authors:  Wenyi Wei; Wendy A Jobling; Wen Chen; William C Hahn; John M Sedivy
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

5.  Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE.

Authors:  Stephanie M Pütz; Fotini Vogiatzi; Thorsten Stiewe; Albert Sickmann
Journal:  Mol Cancer       Date:  2010-09-22       Impact factor: 27.401

6.  Up-regulation of survivin during immortalization of human myofibroblasts is linked to repression of tumor suppressor p16(INK4a) protein and confers resistance to oxidative stress.

Authors:  Chin-Yi Kan; Carlotta Petti; Lauryn Bracken; Michelle Maritz; Ning Xu; Rosemary O'Brien; Chen Yang; Tao Liu; Jun Yuan; Richard B Lock; Karen L MacKenzie
Journal:  J Biol Chem       Date:  2013-02-28       Impact factor: 5.157

7.  Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.

Authors:  Richard A Woo; Randy Y C Poon
Journal:  Genes Dev       Date:  2004-06-01       Impact factor: 11.361

Review 8.  New prospects for targeting telomerase beyond the telomere.

Authors:  Greg M Arndt; Karen L MacKenzie
Journal:  Nat Rev Cancer       Date:  2016-06-24       Impact factor: 60.716

9.  Establishment and characterization of Fabry disease endothelial cells with an extended lifespan.

Authors:  Jin-Song Shen; Xing-Li Meng; Raphael Schiffmann; Roscoe O Brady; Christine R Kaneski
Journal:  Mol Genet Metab       Date:  2007-07-17       Impact factor: 4.797

10.  Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model.

Authors:  Frida Danielsson; Marie Skogs; Mikael Huss; Elton Rexhepaj; Gillian O'Hurley; Daniel Klevebring; Fredrik Pontén; Annica K B Gad; Mathias Uhlén; Emma Lundberg
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.